Procter & Gamble to acquire Thorne for $3.8 billion
Consumer goods giant aims to expand in health and wellness market
1Major acquisition deal
Procter & Gamble is purchasing supplement brand Thorne for $3.8 billion. CEO Shailesh Jejurikar told CNBC the deal will be announced on Tuesday. This move is part of P&G's strategy to grow its health and wellness division. The company already owns health brands like Vick's and Oral-B in its portfolio.
2Thorne's rise
Founded in 1984, Thorne went public in late 2021 with a $525 million valuation. It was taken private by L Catterton in 2023 for $680 million. The brand surpassed $500 million in annual revenue by 2025. CEO Colin Watts told CNBC earlier this year the brand had potential to become billion-dollar business in coming years.
3Young consumer appeal
Most of Thorne's revenue comes from consumers under 40. The brand has seen significant growth in direct-to-consumer sales recently. This demographic trend aligns with P&G's strategy to reach younger consumers. The acquisition could help reduce P&G's reliance on traditional retail channels.
4Market reaction
P&G shares rose less than 1% in Tuesday morning trading following the announcement. This muted response suggests investors are cautious about the deal's impact. However, the health sector investment is expected to contribute to P&G's long-term growth in the evolving wellness market.
5Growing wellness market
The global health and wellness market is projected to reach $1.5 trillion by 2027. P&G's move is part of its strategy to capitalize on increasing consumer interest in healthy living products. The company aims to balance slow growth in traditional segments with high-potential wellness offerings.
6Thorne's operational success
P&G CEO Jejurikar described Thorne as a 'well-run operation.' The brand's long history and proven growth performance influenced the acquisition decision. Thorne's direct-to-consumer success complements P&G's digital transformation goals. This deal could strengthen P&G's e-commerce capabilities significantly.
7Industry consolidation
The consumer health sector has seen increasing strategic acquisitions by major companies in recent years. P&G's move strengthens its position against competitors like Unilever and Nestlé pursuing similar strategies. Analysts predict niche but fast-growing brands will remain prime targets in this consolidation wave.
8Strategic transformation
This acquisition represents a key step in P&G's strategy to shift toward higher-growth potential areas beyond core consumer goods. Through Thorne's expertise and customer base, P&G could establish stronger position in premium health products market. The deal will likely play critical role in P&G's decade-long growth roadmap.